Specialty

Edwards Lifesciences Corporation, the world leader in the science of heart valves, announced that the District Court of Düsseldorf, Germany, today determined that it does not infringe on Cook Inc.’s German transcatheter valve patent.

A Cheshire based medical company Dot Medical, is the only UK Company to offer a unique life saving wearable ‘vest’ that monitors, detects and shocks people having a heart attack.

Invatec, a comprehensive innovator of interventional products, announced CE-certification of a new coronary balloon, the IN.PACT™ Falcon paclitaxel-eluting PTCA balloon catheter.

Cayenne Medical, Inc. announced today that a new Harvard clinical study published in the American Journal of Sports Medicine found that Cayenne’s AperFix® System and “Single Tunnel, Double Bundle™” ACL reconstruction technique better resembles the natural, intact ACL when compared to the more common, “Single-Bundle” technique.

Arobella Medical, LLC, announced European CE Mark approval of its Qoustic Wound Therapy System™ medical device for ultrasound aided wound care.

St. Jude Medical, Inc. announced U.S. Food and Drug Administration approval of the newest version of the Merlin.net™ Patient Care Network, a secure, Internet-based remote care system for patients with implanted medical devices.

KARL STORZ Endoscopy-America, Inc., a world leader in minimally invasive endoscopic technologies and fully integrated operating room solutions, announces that it has entered into a definitive agreement with InTouch Health®, the world leader in Remote Presence healthcare solutions.

Cardinal Health today launched nine new products targeted to improve the safety and efficiency within operating rooms, including high-performance surgical scrubs, a high-tech mobile fluid management system, advances in automated medical supply dispensing and new surgical instruments.

Edwards Lifesciences Corporation, the world leader in the science of heart valves, today announced completion of enrollment in the 350-patient non-surgical study arm of its U.S. pivotal trial — known as the PARTNER Trial — for the Edwards SAPIEN transcatheter aortic heart valve.

Flexible Stenting Solutions Inc. has submitted an Investigational Device Exemption application to the FDA for its FlexStent® Femoropopliteal SE Stent System for the treatment of peripheral artery disease in the superficial femoral and popliteal arteries.

LUMEDX Corporation & Mennen Medical® announced today the signing of a strategic partnership agreement to provide a total, integrated cath lab data solution and seamless stream of hemodynamic cardiovascular patient data to their customers.

Cordis Corporation, a worldwide leader in the field of interventional cardiology, announced plans today to launch a global, head-to-head, randomized clinical trial called NEVO II which will compare the NEVO™ Sirolimus-eluting Coronary Stent to the XIENCE V™ Everolimus-eluting Coronary Stent.

OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of vascular diseases, today announced that it has filed a lawsuit against Boston Scientific Corporation.

Medtronic said Friday that at least 13 people might have died in connection with a heart device that it recalled in 2007 but was still in widespread use.

Medical device pioneer Stentys announced today that it has extended its ‘self-expanding’ and ‘disconnectable’ technology platform to include a second major indication—acute myocardial infarction.

A comprehensive analysis published today in The Lancet from the ABSORB clinical trial demonstrated that Abbott’s bioabsorbable drug eluting stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries within two years.